Future Planet Capital was among the investors that added an undisclosed sum to the $10m in series B funding Congenica raised in February.
Congenica, a UK-based clinical genomics software developer, has closed a series B round of undisclosed size after securing additional funding from investors including spinout-focused investment firm Future Planet Capital.
The second tranche also featured genomics technology provider BGI Genomics and healthcare services provider Healthlink.
Congenica previously achieved a $10m first close in February led by Cambridge University’s patient capital fund Cambridge Innovation Capital, with participation from spinout-focused investment firm Parkwalk Advisors and Amadeus Capital Partners.
Congenica has built a software…